INS and Alzheimer disease: This implies that in patients with AD, impaired cerebral insulin signaling due to neuroinflammation may be a possible link between cerebral dysfunction and T2DM (Ferreira et al., 2014; Mehla et al., 2014; Nasoohi et al., 2018).